Daniel Swerdlow, | |
3800 Reservoir Rd Nw, Washington, DC 20007-2113 | |
(202) 444-3734 | |
Not Available |
Full Name | Daniel Swerdlow |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 37 Years |
Location | 3800 Reservoir Rd Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902882772 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085B0100X | Radiology - Body Imaging | 35440 (District Of Columbia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Georgetown University Hospital | Washington, DC | Hospital |
Medstar Franklin Square Medical Center | Baltimore, MD | Hospital |
Medstar Montgomery Medical Center | Olney, MD | Hospital |
Medstar Good Samaritan Hospital | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstar Medical Group Radiology Llc | 1557589157 | 161 |
Physician Imaging Of Washington Hospital Center Llc | 6204910292 | 81 |
Medstar Medical Group - Southern Maryland Llc | 1355667056 | 195 |
Physician Imaging Of Washington Hospital Center Llc | 6204910292 | 81 |
News Archive
Two INSERM research teams led by Pier Vincenzo Piazza and Giovanni Marsicano (INSERM Unit 862 "Neurocentre Magendie" in Bordeaux) recently discovered that pregnenolone, a molecule produced by the brain, acts as a natural defence mechanism against the harmful effects of cannabis in animals.
Neural activity that reflects the intention to drink alcohol is observed in the prefrontal cortex and is blunted in rats with a family history of excessive drinking, according to research from eNeuro. This insight could lead to novel treatments for alcohol use disorders.
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous side effects.
Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just that.
› Verified 9 days ago
Entity Name | Physician Imaging Of Washington Hospital Center Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831385871 PECOS PAC ID: 6204910292 Enrollment ID: O20080229000143 |
News Archive
Two INSERM research teams led by Pier Vincenzo Piazza and Giovanni Marsicano (INSERM Unit 862 "Neurocentre Magendie" in Bordeaux) recently discovered that pregnenolone, a molecule produced by the brain, acts as a natural defence mechanism against the harmful effects of cannabis in animals.
Neural activity that reflects the intention to drink alcohol is observed in the prefrontal cortex and is blunted in rats with a family history of excessive drinking, according to research from eNeuro. This insight could lead to novel treatments for alcohol use disorders.
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous side effects.
Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just that.
› Verified 9 days ago
Entity Name | Medstar Medical Group Radiology Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326450156 PECOS PAC ID: 1557589157 Enrollment ID: O20140826000263 |
News Archive
Two INSERM research teams led by Pier Vincenzo Piazza and Giovanni Marsicano (INSERM Unit 862 "Neurocentre Magendie" in Bordeaux) recently discovered that pregnenolone, a molecule produced by the brain, acts as a natural defence mechanism against the harmful effects of cannabis in animals.
Neural activity that reflects the intention to drink alcohol is observed in the prefrontal cortex and is blunted in rats with a family history of excessive drinking, according to research from eNeuro. This insight could lead to novel treatments for alcohol use disorders.
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous side effects.
Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just that.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Daniel Swerdlow, Po Box 631856, Baltimore, MD 21263-1856 Ph: () - | Daniel Swerdlow, 3800 Reservoir Rd Nw, Washington, DC 20007-2113 Ph: (202) 444-3734 |
News Archive
Two INSERM research teams led by Pier Vincenzo Piazza and Giovanni Marsicano (INSERM Unit 862 "Neurocentre Magendie" in Bordeaux) recently discovered that pregnenolone, a molecule produced by the brain, acts as a natural defence mechanism against the harmful effects of cannabis in animals.
Neural activity that reflects the intention to drink alcohol is observed in the prefrontal cortex and is blunted in rats with a family history of excessive drinking, according to research from eNeuro. This insight could lead to novel treatments for alcohol use disorders.
For cancer drug developers, finding an agent that kills tumor cells is only part of the equation. The drug must also spare healthy cells, and - ideally - its effects will be reversible, to cut short any potentially dangerous side effects.
Patients with mild to moderate Alzheimer's disease currently have no treatment options to slow brain cell deterioration. Researchers at Houston Methodist's Nantz National Alzheimer Center are studying an investigational drug that proposes to do just that.
› Verified 9 days ago
Kimberly Smith, Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-902-1073 | |
Dr. Michael B Shvarts, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7000 | |
Joel Bowers, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1150 Varnum St Ne, Washington, DC 20017 Phone: 202-269-7000 | |
Krista Lyn Mcfarren, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite 102, Washington, DC 20016 Phone: 202-966-0606 Fax: 202-244-6757 | |
Ranjith Vellody, MD Radiology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Aaron Conard, Radiology Medicare: Not Enrolled in Medicare Practice Location: 5255 Loughboro Rd Nw, Washington, DC 20016 Phone: 240-366-7325 | |
Dr. Estelle Cooke-sampson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw Ste 6101, Washington, DC 20060 Phone: 202-865-6679 Fax: 202-865-3138 |